Combined Synopsis/SolicitationPosted Sep 10, 2026·Original deadline passed (Sep 17). See latest amendment for current deadline.

Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis� (ALS) Biorepository in support of the ALS Registry Act

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Open solicitation
NAICS
621991
Value
Not stated
Solicitation
75D301-Q-26-95343
Set-aside
Small Business Set Aside - Total
PSC
R499
Place
GA, USA
Contact
Howard D. Bish (uwo8@cdc.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D301-Q-26-95343 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 10, 2026
    Combined Synopsis/Solicitation
    Open
  • Sep 10, 2026 · this notice
    Combined Synopsis/Solicitation
  • Sep 14, 2026
    Combined Synopsis/Solicitation
    Open
Award
Not yet. Too few past cases at this agency to estimate timing (7 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 75D301-26-Q-95343 is issued as a Request for Quotation for the project titled: "Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis� (ALS) Biorepository in support of the ALS Registry Act." This acquisition is set-aside for small business concerns. This solici… (show all)

tation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. (ii) A list of line-item number(s) and items, quantities, and units of measure can be found in the solicitation document. (iii) Description of requirements for the items to be acquired, including documentation supporting any brand name descriptions (see 12.102). See Solicitation document. (iv) Date(s) and place(s) of delivery and acceptance and f.o.b. point (see part 47). Period of performance is anticipated to be 9/28/2026 - 9/27/2031, inclusive of the base period and all option periods. (v) A list of solicitation provisions that apply to the acquisition (see 12.205(a)). See solicitation document. (vi) A list of contract clauses that apply to the acquisition (see 12.205(b)). See solicitation document. (vii) The date, time, and place for receipt of offer and point of contact. Offers are due 9/17/2026 10 AM ET to uwo8@cdc.gov. (viii) Any other additional information required by 5.101(c). Questions are due 9/11/2026 5 PM ET to uwo8@cdc.gov. Update 1: 9/10/2026 Add Attachment 1 Artificial Intelligence (AI) Use Compliance and Risk Management Plan.

Who won similar work

13 award notices on SAM.gov in the last 24 months. Matched by: Same office (CDC OFFICE OF ACQUISITION SERVICES), same product/service code (PSC) R499.

Single-winner award sizes (9): middle half $737K to $4.0M, median $2.2M; range $395K to $28.1M.

WinnerAwardsValueLast
STRATEGIC INNOVATIVE SOLUTIONS LLC2$1.2MMar 17, 2026
DECISIONPOINT CORPORATION1$28.1MSep 9, 2026
RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA1$6.5MJun 4, 2026
DELOITTE CONSULTING LLP1$4.0MAug 19, 2025
IMPLENOMICS LLCS Marblehead MA 01945 USA1$2.6MMar 17, 2026
DAVIS PROFESSIONAL SERVICES, LLC1$2.2MApr 23, 2026
WINDSOR GROUP LLC1$1.4MMar 4, 2026
POLOLEI SOLUTIONS, LLC1$395KMay 27, 2026
INBIOS INTERNATIONAL INC1– + 1 sharedJan 7, 2026
CEPHEID Sunnyvale CA 94089 USA1– + 1 sharedJan 7, 2026

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (0 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.